Correlation Between Circulating Tumor DNA Levels and Response to Tyrosine Kinase Inhibitors (TKI) Treatment in Non-Small Cell Lung Cancer

BACKGROUND: Clinical monitoring of EGFR-positive NSCLC patients is important to gauge treatment response. The current study addresses the usage of circulating tumor DNA (ctDNA) as a prognostic marker during treatment of first-generation TKIs. MATERIAL/METHODS: Serial samplings of peripheral blood fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhangjing, Wang, Wenyue, Shu, Zitan, Zhou, Xue, Zhang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540003/
https://www.ncbi.nlm.nih.gov/pubmed/28742791
http://dx.doi.org/10.12659/MSM.902265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540003/
https://www.ncbi.nlm.nih.gov/pubmed/28742791
http://dx.doi.org/10.12659/MSM.902265

Ejemplares similares